We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current BJTRF market cap is 542.78M. The company's latest EPS is HKD 0.6456 and P/E is 1.01.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| HKD (元) | HKD (元) | HKD (元) | HKD (元) | HKD (元) | |
| Total Revenue | 1.43B | 1.32B | 1.56B | 1.73B | 1.52B |
| Operating Income | 646.9M | 644.27M | 778.2M | 806.92M | 633.69M |
| Net Income | 556.12M | 542.46M | 607.84M | 645.88M | 540.39M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| HKD (元) | HKD (元) | HKD (元) | HKD (元) | HKD (元) | |
| Total Assets | 3.14B | 3.42B | 3.83B | 4.23B | 4.43B |
| Total Liabilities | 372.69M | 287.46M | 295.48M | 486.49M | 413.76M |
| Total Equity | 2.77B | 3.13B | 3.54B | 3.74B | 4.02B |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| HKD (元) | HKD (元) | HKD (元) | HKD (元) | HKD (元) | |
| Operating | 551.01M | 116.05M | 777.17M | 547.44M | 460.83M |
| Investing | 835.54M | 506.73M | -265.73M | 335.41M | -1.08B |
| Financing | -878.67M | -264.3M | -278.65M | -535.42M | -372.18M |
| Market Cap | 542.78M |
| Price to Earnings Ratio | 1.01 |
| Price to Sales Ratio | 0.36 |
| Price to Cash Ratio | 0.54 |
| Price to Book Ratio | 0.14 |
| Dividend Yield | - |
| Shares Outstanding | 837.1M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | -56.77% |
| 52 Week High | 1.50 |
| 52 Week Low | 0.6484 |
| Spread (Intraday) | 1 (57.58%) |
| Company Name | Beijing Tong Ren Tang Chinese Medicine Company Ltd (PK) |
| Address |
room 1405–1409, office tower wan chai, wan chai |
| Website | https://www.tongrentangcm.com |
| Industry | drug & proprietary stores (5912) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
